packageLiraglutide

liraglutide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Liraglutide is a GLP-1 analogue used as an anti-diabetic medicine to treat type 2 diabetes and glucose intolerance, and is also authorised for obesity and overweight. It is approved and authorised in the European Union, and is widely used for diabetes care.

Summary written by glm-5.3-flash from Wikidata Q2526479 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:liraglutide
ATC codes:A10BJ02
DrugBank:DB06655
ChEBI:71193
Wikidata:Q2526479
molar mass:3751 g/mol (Drugs.Common 25.09, not verified)
logP:-3.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown